Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides

Journal of Cellular Physiology

Volumn 207, Issue 1, 2006, Pages 244-250

  Amcheslavsky, Alla ^a   Bar Shavit, Zvi ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CPG OLIGODEOXYNUCLEOTIDE; DINUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12 ANTIBODY; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING;

ACID PHOSPHATASE; ANIMALS; ANTIBODIES; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; ISOENZYMES; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NFATC TRANSCRIPTION FACTORS; OLIGODEOXYRIBONUCLEOTIDES; OSTEOCLASTS; PROTEIN SUBUNITS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 33644896862     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20563     Document Type: Article

References (54)

1. Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL. 1997. Lipopolysaccharide- stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100:1557-1565.
2. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2:675-680.
3. Amcheslavsky A, Zou W, Bar-Shavit Z. 2004. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms. Implications for osteoclastogenesis. J Biol Chem 279:54039-54045.
4. Amcheslavsky A, Hemmi H, Akira S, Bar-Shavit Z. 2005. Differential contribution of Osteoclast- and Osteoblast-Lineage cells to CpG- Oligodeoxynucleotide (CpG-ODN) modulation of Osteoclastogenesis. J Bone Miner Res 20: 1692-1699.
5. Bi Y, Seabold JM, Kaar SG, Ragab AA, Goldberg VM, Anderson JM, Greenfield EM. 2001. Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 16:2082-2091.
6. Chiang CY, Kyritsis G, Graves DT, Amar S. 1999. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 67:4231-4236.
7. Cowdery JS, Boerth NJ, Norian LA, Myung PS, Koretzky GA. 1999. Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide. J Immunol 162:6770-6775.
8. Fantuzzi L, Puddu P, Varano B, Del Corno M, Belardelli F, Gessani S. 2000. IFN-alpha and IL-18 exert opposite regulatory effects on the IL-12 receptor expression and IL-12-induced IFN-gamma production in mouse macrophages: Novel pathways in the regulation of the inflammatory response of macrophages. J Leukoc Biol 68:707-714.
9. Fox SW, Chambers TJ. 2000. Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis. Biochem Biophys Res Commun 276:868-872.
10. Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H. 2003. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. J Immunol 171:5130-5139.
11. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
12. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. 2001. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 166:4915-4921.
13. Huang W, O'Keefe RJ, Schwarz EM. 2003. Exposure to receptor-activator of NFκB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation. Arthritis Res Ther 5:R49-R58.
14. Ishihara Y, Nishihara T, Maki E, Noguchi T, Koga T. 1991. Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide. J Periodontal Res 26:155-160.
15. Ito HO, Shuto T, Takada H, Koga T, Aida Y, Hirata M, Koga T. 1996. Lipopolysaccharides from Porphyromonas gingivalis, Prevotella intermedia and Actinobacillus actinomycetemcomitans promote osteoclastic differentiation in vitro. Arch Oral Biol 41:439-444.
16. Kamolmatyakul S, Chen W, Li YP. 2001. Interferon-gamma downregulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation. J Dent Res 80:351-355.
17. Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T, Yoshikai Y. 2001. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 166:3574-3579.
18. Kitaura H, Nagata N, Fujimura Y, Hotokezaka H, Yoshida N, Nakayama K. 2002. Effect of IL-12 on TNF-alpha-mediated osteoclast formation in bone marrow cells: Apoptosis mediated by Fas/Fas ligand interaction. J Immunol 169:4732-4738.
19. Klinman DM. 2003. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 2:305-315.
20. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM. 1996. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 93:2879-2883
21. Krieg AM. 2001. Now I know my CpGs. Trends Microbiol 9:249-252.
22. Krieg AM. 2002. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709-760.
23. Krieg AM. 2003. CpG motifs: The active ingredient in bacterial extracts? Nat Med 9:831-835.
24. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
25. Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, Kim HH. 2002. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30:71-77.
26. Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T, Suda T, Takahashi N, Baek JH. 2002. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143: 3105-3113.
27. Matsumoto M, Sudo T, Saito T, Osada H, Tsujimoto M. 2000. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κ B ligand (RANKL). J Biol Chem 275: 31155-31161.
28. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL. 2000. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105:433-440.
29. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397.
30. Millar SJ, Goldstein EG, Levine MJ, Hausmann E. 1986. Modulation of bone metabolism by two chemically distinct lipopolysaccharide fractions from Bacteroides gingivalis. Infect Immun 51:302-306.
31. Munder M, Mallo M, Eichmann K, Modolell M. 1998. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation. J Exp Med 187:2103-2108.
32. Musikacharoen T, Oguma A, Yoshikai Y, Chiba N, Masuda A, Matsuguchi T. 2005. Interleukin-15 induces IL-12 receptor beta1 gene expression through PU.1 and IRF3 by targeting chromatin remodeling. Blood 105:711-720.
33. Nagata N, Kitaura H, Yoshida N, Nakayama K. 2003. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: Involvement of IFN-gamma possibly induced from non-T cell population. Bone 33: 721-732.
34. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. 1996. Bacterially induced bone destruction: Mechanisms and misconceptions. Infect Immun 64:2371-2380.
35. Orcel P, Feuga M, Bielakoff J, De Vernejoul MC. 1993. Local bone injections of LPS and M-CSF increase bone resorption by different pathways in vivo in rats. Am J Physiol 264:E391-E397.
36. Puddu P, Fantuzzi L, Borghi P, Varano B, Rainaldi G, Guillemard E, Malorni W, Nicaise P, Wolf SF, Belardelli F, Gessani S. 1997. IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J Immunol 159: 3490-3497.
37. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. 1998. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95:588-593.
38. Schindler H, Lutz MB, Rollinghoff M, Bogdan C. 2001. The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J Immunol 166:3075-3082.
39. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
40. Takami M, Kim N, Rho J, Choi Y. 2002. Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol 169:1516-1523.
41. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901.
42. Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T. 2002a. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416:744-749.
43. Takeshita F, Klinman DM. 2000. CpG ODN-mediated regulation of IL-12 p40 transcription. Eur J Immunol 30:1967-1976.
44. Takeshita S, Kaji K, Kudo A. 2000. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 15:1477-1488.
45. Wagner H. 2001. Toll meets bacterial CpG-DNA. Immunity 14:499-502.
46. Wagner H. 2004. The immunobiology of the TLR9 subfamily. Trends Immunol 25:381-386.
47. Yamada N, Niwa S, Tsujimura T, Iwasaki T, Sugihara A, Futani H, Hayashi S, Okamura H, Akedo H, Terada N. 2002. Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity. Bone 30:901-908.
48. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
49. Yi AK, Peckham DW, Ashman RF, Krieg AM. 1999. CpG DNA rescues B cells from apoptosis by activating NF-κB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway. Int Immunol 11:2015-2024.
50. Yi AK, Yoon JG, Yeo SJ, Hong SC, English BK, Krieg AM. 2002. Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: Central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response. J Immunol 168:4711-4720.
51. Zou W, Bar-Shavit Z. 2002. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17:1211-1218.
52. Zou W, Hakim I, Tschoep K, Endres S, Bar-Shavit Z. 2001. Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J Cell Biochem 83:70-83.
53. Zou W, Schwartz H, Endres S, Hartmann G, Bar-Shavit Z. 2002. CpG oligonucleotides: Novel regulators of osteoclast differentiation. FASEB J 16:274-282.
54. Zou W, Amcheslavsky A, Bar-Shavit Z. 2003. CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9. J Biol Chem 278:16732-16740.